Joining forces against hypoglycaemia and diabetes

Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia, industry and civil society - among which SIB's Vital-IT Group and the University of Lausanne - have joined forces to find better solutions to alleviate the burden and consequences of hypoglycaemia, a common and serious complication of diabetes.
This project is supported by the Innovative Medicines Initiative (IMI), Europe’s largest public-private initiative aiming to improve health by speeding up the development of, and patient access to, innovative medicines.

Read the international press release (EN)

Related news

Novel molecular insights into diabetic beta cells
SIB accelerates the fight against diabetes with several pan-European projects
RHAPSODY, a European symphony for personalized health of diabetes